Delivered Revenue At the High End of the GuidanceImproved Gross Margin and Generated Strong Cash Flow From OperationsMARLBOROUGH, Mass., Feb.
Q3 2025 Earnings Call Transcript February 10, 2025 Columbus McKinnon Corporation misses on earnings expectations. Reported ...
Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果